Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70.RBC Capital Markets anticipates a favorable second-quarter
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by
Chevron Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 — Wolfe Research Reinstates → Peer Perform 07/17/2024 2.62% Bernstein $183 → $167 Downgrades
Procter & Gamble's Options Frenzy: What You Need to Know
Investors with a lot of money to spend have taken a bullish stance on Procter & Gamble (NYSE:PG).And retail traders should know.We noticed this today when the positions showed up on publicly
Top 10 S&P 500 Stocks Down More Than 5% From Last Week
10 Financials Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity
UnitedHealth Group Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 20.23% UBS $640 → $680 Maintains Buy 07/17/2024 6.09% Argus Research $570 → $600 Maintains
Smart Money Is Betting Big In WMT Options
Investors with a lot of money to spend have taken a bullish stance on Walmart (NYSE:WMT).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Goldman Sachs, Morgan Stanley and Bank of America Continued The Strong Trend With Their Second Quarter Financials
On Monday, bank earnings continued with The Goldman Sachs Group Inc (NYSE:GS), also joining the trend of topped profit and revenue estimates on the back of better-than-expected fixed income results
These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results
Johnson & Johnson (NYSE:JNJ) reported better-than-expected second-quarter earnings on Wednesday.The company posted adjusted EPS of $2.82, up 10.2% year-over-year, beating the consensus of $2.70. The
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Market Whales and Their Recent Bets on UNH Options
Deep-pocketed investors have adopted a bullish approach towards UnitedHealth Group (NYSE:UNH), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga
Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an
RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
RBC Capital analyst Shagun Singh reiterates Johnson & Johnson (NYSE:JNJ) with a Outperform and maintains $175 price target.
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Least Shorted S&P 500 Stocks in June
Exxon Dispute in Chevron-Hess Deal Hinges on Guyana Asset Change of Control - Reuters
Bank of America Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 -9.07% BMO Capital $38 → $40 Maintains Market Perform 07/17/2024 4.57% Morgan Stanley $44 → $46
American Express Earnings Preview: Low Double-Digit Profit Growth Will Be Welcomed as the Market Shifts Toward the Finance Sector
American Express, one of Berkshire Hathaway's largest holdings, will release its Q2 financial report before the bell on Friday. The upcoming earnings are expected to be bolstered by robust gains in loans and card fees, stringent cost management, and solid credit outcomes.
Berkshire Hathaway Hits Record High; Will US Stocks Shift From Tech-Driven to Value-Driven?
The